53 Results for "

Protein kinase inhibitor1

" in MedChemExpress (MCE) Product Catalog:
Products (53)

53 Results for "Protein kinase inhibitor1" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-U00439
CAS No.: 1365986-44-2
Target:  

DYRK

Research Areas:  

Cancer

Protein kinase inhibitor 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-U00439A
CAS No.: 2321337-71-5
Target:  

DYRK

Research Areas:  

Cancer

Protein kinase inhibitor 1 hydrochloride is a potent HIPK2 inhibitor, with IC50s of 136 and 74 nM for HIPK1 and HIPK2, and a Kd of 9.5 nM for HIPK2.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0222
CAS No.: 99534-03-9
Target:  

PKA

Research Areas:  

Others

PKI(5-24) is a potent, competitive, and synthetic peptide inhibitor of PKA (cAMP-dependent protein kinase), with a Ki of 2.3 nM. PKI(5-24) corresponds to residues 5-24 in the naturally occurring heat-stable protein kinase inhibitor .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P80774A
Synonyms: CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1; Cyclin-dependent kinase inhibitor 1; CDK-interacting Protein 1; Melanoma differentiation-associated Protein 6; MDA-6; p21

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-126146
CAS No.: 2328094-11-5
Purity:  99.60%
Target:  

PKC AMPK

Research Areas:  

Metabolic Disease Cancer

PKC-iota inhibitor 1 is a protein kinase C-iota (PKC-ι) inhibitor with an IC50 value of 0.34 μM. PKC-iota inhibitor 1 can be used for the study of cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-156237
CAS No.: 1243063-73-1
Purity:  99.88%
Target:  

Autophagy

Research Areas:  

Others

Beclin1-ATG14L interaction inhibitor 1 (com 19) is a selective Beclin1-ATG14L interaction inhibitor. This protein interaction mechanism specifically targets complex I of the lipid kinase VPS34 without affecting complex II. Because the integrity of VPS34 complex II depends on the Beclin 1-UVRAG interaction. Beclin1-ATG14L interaction inhibitor 1 can disrupt the formation of VPS34 complex I and inhibit autophagy, but does not affect complex II-related vesicle transport .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100984
CAS No.: 84468-24-6
Purity:  99.87%
Target:  

PKA PKC Myosin ROCK

Research Areas:  

Cancer

HA-100 is a potent protein kinase inhibitor, with IC50s of 4 μM, 8 μM, 12 μM and 240 μM for cGMP-dependent protein kinase (PKG), cAMP-dependent protein kinase (PKA), protein kinase C (PKC) and MLC-kinase, respectively. HA-100 also used as a ROCK inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-77251
CAS No.: 1315330-11-0
Target:  

MAP4K MAP3K

Research Areas:  

Cancer

TAK1/MAP4K2 inhibitor 1 is a potent dual TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2) inhibitor, with IC50s of 41.1 nM and 18.2 nM, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P86368
Synonyms: Cyclin-dependent kinase inhibitor 1 ; CDK-interacting Protein 1; Melanoma differentiation-associated Protein 6; MDA-6; p21;

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80773
Synonyms: CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1; Cyclin-dependent kinase inhibitor 1; CDK-interacting Protein 1; Melanoma differentiation-associated Protein 6; MDA-6; p21

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-148297
CAS No.: 2382811-41-6
Purity:  98.75%
Synonyms: LY3871801; R 552
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

Ocadusertib is a potent Serine/Threonine kinase receptor-interacting protein kinase 1 (RIPK1) inhibitor .
loading...
    loading...
Cat. No.: HY-160144S
CAS No.: 2328068-29-5
Synonyms: BMS-986322
Lomedeucitinib (BMS-986322) is a tyrosine protein kinase (TYK2) inhibitor .
loading...
    loading...
Cat. No.: HY-101664
CAS No.: 172152-36-2
Purity:  99.97%
Synonyms: IY-81149
Target:  

Proton Pump TOPK

Research Areas:  

Inflammation/Immunology Cancer

Ilaprazole (IY-81149) is an orally active proton pump inhibitor. Ilaprazole irreversibly inhibits H +/K +-ATPase in a dose-dependent manner with an IC50 of pump inhibitory activity of 6 μM in rabbit parietal cell preparation. Ilaprazole is used for the research of gastric ulcers. Ilaprazole is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor .
loading...
    loading...
Cat. No.: HY-B2145
CAS No.: 172152-50-0
Synonyms: IY-81149 sodium
Target:  

Proton Pump TOPK

Research Areas:  

Inflammation/Immunology Cancer

Ilaprazole (IY-81149) sodium is an orally active proton pump inhibitor. Ilaprazole sodium irreversibly inhibits H +/K +-ATPase in a dose-dependent manner with an IC50 of 6 μM in rabbit parietal cell preparation. Ilaprazole sodium is used for the research of gastric ulcers. Ilaprazole sodium is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor .
loading...
    loading...
Cat. No.: HY-107024
CAS No.: 105250-85-9
Purity:  99.77%
Synonyms: OGP(10-14); Historphin
Target:  

Src

Research Areas:  

Others

Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity. Osteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway. Osteogenic Growth Peptide (10-14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acts as a Src inhibitor .
loading...
    loading...
Cat. No.: HY-126328
CAS No.: 1160501-81-4
Purity:  99.73%
Target:  

PKC Interleukin Related

Research Areas:  

Inflammation/Immunology

PKC-theta inhibitor 1 is an orally active and selective ATP-competitive inhibitor of Protein Kinase Cθ (PKCθ), with a Ki value of 6 nM. PKC-theta inhibitor 1 inhibits T-cell-mediated inflammatory responses by suppressing the release of proinflammatory cytokines (IL-2 IC50 = 0.21 μM in anti-CD3/CD28-stimulated PBMCs; IL-17 IC50 = 1 μM in CD3/CD28-stimulated Th17 cells) PKC-theta inhibitor 1 significantly reduces symptoms in mice with ongoing experimental autoimmune encephalomyelitis (EAE). PKC-theta inhibitor 1 can be used for the study of T-cell-mediated inflammatory diseases such as multiple sclerosis .
loading...
    loading...
Cat. No.: HY-W412264
CAS No.: 6320-51-0
Target:  

Pim

Research Areas:  

Cancer

Pim-1/2 kinase inhibitor 1 is an orally active pim-1/2 kinase inhibitor. Pim-1/2 kinase inhibitor 1 blocks the ability of Pim kinases to phosphorylate peptides, and inhibits the pim protein kinase directed phosphorylation of 4E-BP1 and p27 Kip1. Pim-1/2 kinase inhibitor 1 can be used in study of cancer, especially prostate cancer .
loading...
    loading...
Cat. No.: HY-143657
CAS No.: 2366279-99-2
Purity:  99.88%
Target:  

Myosin Ferlin Family MMP

Research Areas:  

Cancer

Myoferlin inhibitor 1 is a compound that exhibits reversible, concentration-dependent binding to the myoferlin MYOF-C2D protein, with a KD of 0.094 μM. Myoferlin inhibitor 1 shows potent anti-invasion and anti-migration activities against different pancreatic cancer cells. Myoferlin inhibitor 1 inhibits pancreatic cancer metastasis through reversing mesenchymal transition (EMT), inhibiting the secretions of MMP1 and MMP2 and blocking the receptor tyrosine kinases. Myoferlin inhibitor 1 displays effective antimetastatic activities in pancreatic cancer in vitro and in vivo. Myoferlin inhibitor 1 can be used in research on preventing pancreatic cancer metastasis .
loading...
    loading...
Cat. No.: HY-124321
CAS No.: 53734-79-5
Target:  

CDK

Research Areas:  

Cancer

Metralindole hydrochloride is an inhibitor of human cyclin-dependent kinase CDK2 and human protein kinase CK2 holoenzyme. Metralindole hydrochloride shows good potential as a non-small cell lung cancer inhibitor .
loading...
    loading...
Cat. No.: HY-124761
CAS No.: 683808-78-8
Research Areas:  

Cancer

Poloppin is a potent, cell penetrant inhibitor of the mitotic Polo-like kinase (PLK) (IC50=26.9 μM) and prevents the protein-protein interaction via the Polo-box domain (PBD) (Kd= 29.5 μM). Poloppin selectively kills cells expressing mutant KRAS, enhancing death in mitosis. Poloppin is used for the study of KRAS-mutant cancers as single agents, or in combination with c-MET inhibitors .
loading...
    loading...